SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-058200
Filing Date
2024-05-13
Accepted
2024-05-13 07:30:38
Documents
83
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q itrm-20240331.htm   iXBRL 10-Q 2381056
2 EX-31.1 itrm-ex31_1.htm EX-31.1 16168
3 EX-31.2 itrm-ex31_2.htm EX-31.2 16413
4 EX-32.1 itrm-ex32_1.htm EX-32.1 9624
5 EX-32.2 itrm-ex32_2.htm EX-32.2 9616
  Complete submission text file 0000950170-24-058200.txt   10464915

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT itrm-20240331.xsd EX-101.SCH 1690526
87 EXTRACTED XBRL INSTANCE DOCUMENT itrm-20240331_htm.xml XML 1787313
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38503 | Film No.: 24936879
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)